Chitosan-xanthan gum microparticle-based oral tablet for colon-targeted and sustained delivery of quercetin

Journal of Microencapsulation

Volumn 31, Issue 7, 2014, Pages 694-699

  Caddeo, Carla ^a   Nácher, Amparo ^b,c   Díez Sales, Octavio ^b,c   Merino Sanjuán, Matilde ^b,c   Fadda, Anna Maria ^a   Manconi, Maria ^a  

^a UNIVERSITY OF CAGLIARI   (Italy)

^b UNIVERSITY OF VALENCIA   (Spain)

^c UNIVERSITAT POLITÈCNICA DE VALÈNCIA   (Spain)

Author keywords

Chitosan; Colon drug delivery; Microparticle tablets; Microparticles; Quercetin; Xanthan gum

Indexed keywords

CHITOSAN; EUDRAGIT; QUERCETIN; XANTHAN; ANTIOXIDANT; BACTERIAL POLYSACCHARIDE; DELAYED RELEASE FORMULATION; TABLET;

ALKALINITY; ARTICLE; COLON; DIFFERENTIAL SCANNING CALORIMETRY; DRUG BIOAVAILABILITY; DRUG DEGRADATION; DRUG DELIVERY SYSTEM; DRUG MECHANISM; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HYDROGEL; INFLAMMATORY DISEASE; POLYMERIZATION; SCANNING ELECTRON MICROSCOPY; SINGLE DRUG DOSE; SOLID STATE; SUSTAINED DRUG RELEASE; TABLET; X RAY DIFFRACTION; CHEMISTRY; DELAYED RELEASE FORMULATION; ORAL DRUG ADMINISTRATION; PH;

ADMINISTRATION, ORAL; ANTIOXIDANTS; CHITOSAN; COLON; DELAYED-ACTION PREPARATIONS; HYDROGEN-ION CONCENTRATION; POLYSACCHARIDES, BACTERIAL; QUERCETIN; TABLETS;

EID: 84911493877     PISSN: 02652048     EISSN: 14645246     Source Type: Journal    
DOI: 10.3109/02652048.2014.913726     Document Type: Article

References (23)

1. Alhnan MA Murdan S Basit AW. Encapsulation of poorly soluble basic drugs into enteric microparticles: A novel approach to enhance their oral bioavailability. Int J Pharm, 2011;416:55-60.
2. Boots AW Haenen GR Bast A. Health effect of quercetin: From antioxidant to nutraceutical. Eur J Pharmacol, 2008;585:325-37.
3. Caddeo C Teskac? K Sinico C Kristl J. Effect of resveratrol incorporated in liposomes on proliferation and UV-B protection of cells. Int J Pharm, 2008;363:183-91.
4. Cadde o C Manconi M Fadda AM Lai F Lampis S Diez-Sales O Sinico C. Nanocarriers for antioxidant resveratrol: Formulation approach, vesicle self-assembly and stability evaluation. Colloid Surf B-Biointerfaces, 2013;111:327-32.
5. Caddeo C Dié z-Sales O Pons R Fernàndez-Busquets X Fadda AM Manconi M. Topical anti-inflammatory potential of quercetin in lipid-based nanosystems: In vivo and in vitro evaluation. Pharm Res, 2014;31:959-68.
6. Chessa M Caddeo C Valenti D Manconi M Sinico C Fadda AM. Effect of penetration enhancer containing vesicles on the percutaneous delivery of quercetin through new born pig skin. Pharmaceutics, 2011;3:497-509.
7. Eftaiha AF Qinna N Rashid IS Al Remawi MM Al Shami MR Arafat TA Badwan AA. Bioadhesive controlled metronidazole release matrix based on chitosan and xantha n gum. Mar Drugs, 2010;8: 1716-30.
8. Korsmeyer RW Gunny R Peppas NA. Mechanism of solute release from hydrophilic polymers. Int J Pharm, 1983;15:25-35.
9. Kristl J T eskac? K Caddeo C Abramovic? Z Sentjurc M. Improvements of cellular stress response on resveratrol in liposomes. Eur J Pharm Biopharm, 2009;73:253-9.
10. Kumar MNVR Muzzarelli RAA Muzzarelli C Sashiwa H Domb AJ.Chitosan chemistry and pharmaceutical perspectives Chem Rev 2004 104 6017-84.
11. Manach C Scalbert A Morand C Rémésy C Jimé nez L. Polyphenols: Food sources and bioavailability. Am J Clin Nutr, 2004;79:727-47.
12. Manconi M Mura S Manca ML Fadda AM Dolz M Hernandez MJ Casanovas A Diéz-S ales O. Chitosomes as drug delivery systems for C-phycocyanin: Preparation and characterization. Int J Pharm, 2010; 392:92-100.
13. Mc Callion ONM Taylor KMG Thomas M Taylor AJ. The influence of surface tension on aerosols produced by medical nebulisers. Int J Pharm, 1996;129:123-36.
14. Mura C Ná cher A Merino V Merino-Sanjuán M Manconi M Loy G Fadda AM Diéz-Sales O. Design, characterization and in vitro evaluation of 5-aminosalicylic acid loaded n-succinyl-chitosan microparticles for colon specific delivery. Colloid Surf B-Biointerfaces, 2012;94:199-205.
15. Noory C Tran N Ouderkir k L Shah V. Steps for development of a dissolution test for sparingly water-soluble drug products. Am Pharmaceut Rev, 2002;5:16-20.
16. Pinto JF. Site-specific drug delivery systems within the gastrointestinal tract: From the mouth to the colon. Int J Pharm, 2010;395: 44-52.
17. Rahman SMH Telny TC Ravi TK Kuppusamy S. Role of surfactant and pH in dissolution of curcumin. Indian J Pharm Sci, 2009;71:139-42.
18. Shan BE Wang MX Li RQ. Quercetin inhibit human SW480 colon cancer growth in association with inhibition of cyclin D1 and survivin expression through Wnt/-catenin signaling pathway. Cancer Invest, 2009;27:604-12.
19. Siepmann J Peppas NA. Modeling of drug release from delivery systems based on hydroxypropyl methylcellulose (HPMC). Adv Drug Deliv Rev, 2001;48:139-57.
20. Singhal A Hain J Singhal V Elias EJ Showkat A. Colon-targeted quercetin delivery using natural polymer to enhance its bioavailability. Pharmacognosy Res, 2011;3:35-9.
21. Sinico C Caddeo C Valenti D Fadda AM Bilia AR Vincieri FF. Liposomes as carriers for verbascoside: Stability and skin permeation studies. J Liposome Res, 2008;18:83-90.
22. Xu Q Tanaka Y Czernuszka JT. Encapsulation and release of a hydrophobic drug from hydroxyapatite coated liposomes. Biomaterials, 2007 a;28:2687-94.
23. Xu Y Zhan C Fan L Wang L Zheng H. Preparation of dual crosslinked alginate-chitosan blend gel beads and in vitro controlled release in oral site specific drug delivery system. Int J Pharm, 2007b ; 336:329-37.